INS and Cognitive impairment: Consequently, the evaluation of serum proinsulin levels may offer a valuable tool for identifying non-diabetic individuals with cognitive impairment who could benefit from emerging Alzheimer’s treatments associated with the insulin pathway, such as GLP1-RA.